奥美罗斯制药

最新新闻

• 公司公告
  4: Omeros | 4: Statement of changes in beneficial ownership of securities-Director Hood Leroy E. MD PhD
  SEC · 2026/6/22
• 公司公告
  4: Omeros | 4: Statement of changes in beneficial ownership of securities-Officer Borges David J.
  SEC · 2026/7/25
• 评级变动
  Omeros Is Maintained at Buy by D. Boral Capital
  Dow Jones · 2026/4/21
• 公司公告
  Omeros | 4: Statement of changes in beneficial ownership of securities-Officer Borges David J.
  SEC · 2026/9/25
• H.C. Wainwright Maintains Omeros(OMER.US) With Buy Rating, Maintains Target Price $33
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 公司公告
  4: Omeros | 4: Statement of changes in beneficial ownership of securities-Director Cable Thomas J.
  SEC · 2026/6/22
• 评级变动
  OMER S.p.A.: Resilient Fundamentals and Structural Growth Support Buy Rating Despite Softer FY26 Outlook
  TipRanks · 2026/4/3
• Omeros Q2 Adj. EPS $0.02 Beats $(0.27) Estimate, Sales $28.529M Beat $12.700M Estimate
  Benzinga · 2026/8/13
• 评级变动
  H.C. Wainwright Maintains Omeros(OMER.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/6/10
• 评级变动
  WBB Securities Maintains Omeros(OMER.US) With Buy Rating, Raises Target Price to $55
  \u5e02\u573a\u8d44\u8baf · 2026/1/8
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), PepGen Inc. (PEPG) and Omeros (OMER)
  TipRanks · 2026/4/1
• 评级变动
  HC Wainwright & Co. Maintains Buy on Omeros, Lowers Price Target to $33
  Benzinga · 2026/6/26
• 公司公告
  4: Omeros | 4: Statement of changes in beneficial ownership of securities-Director Perkinson Diana T.
  SEC · 2026/6/22
• 评级变动
  Omeros Price Target Maintained With a $36.00/Share by D. Boral Capital
  Dow Jones · 2026/4/21
• Cantor Fitzgerald Initiates Omeros(OMER.US) With Buy Rating, Announces Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• Needham Maintains Omeros(OMER.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Omeros Is Maintained at Buy by HC Wainwright & Co.
  Dow Jones · 2026/1/8
• 评级变动
  Needham Maintains Omeros(OMER.US) With Hold Rating, Announces Target Price $10.72
  \u5e02\u573a\u8d44\u8baf · 2026/6/26
• 评级变动
  D. Boral Capital Maintains Buy on Omeros, Maintains $36 Price Target
  Benzinga · 2026/1/27
• H.C. Wainwright Maintains Omeros(OMER.US) With Buy Rating, Cuts Target Price to $33
  \u5e02\u573a\u8d44\u8baf · 2026/6/27

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。